NewsBenzingaZhengye Biotechnology H1 BPA de $(0,06), igual interanual, ventas de $7,509 millones, por debajo de los $8,701 millones interanuales Zhengye Biotechnology H1 BPA de $(0,06), igual interanual, ventas de $7,509 millones, por debajo de los $8,701 millones interanuales Benzinga 2026.11.12 22:10 (GMT+0) Open on Benzinga Other news Ardent Health Stock Tumbles 14.61% After Hours: Here's Why Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’ Abdul El-Sayed Tells Trump He Has Chance to ‘Heal the Sick’: Senator-Elect Says ‘People Really Want Health Care’ Reported Earlier, SPAC Berto To Combine With AMPERA At About $900M Pre-Money Equity Value; Up To $357M Gross Cash Proceeds Expected Iridex (NASDAQ: IRIX) Shares Fall 26.96% After Hours: What Investors Should Know
Lowe's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Elon Musk Had a Facepalm Moment After Sean Duffy Defends Rejecting Free Starlink for FAA: ‘Our Airspace Is Very Big’
Abdul El-Sayed Tells Trump He Has Chance to ‘Heal the Sick’: Senator-Elect Says ‘People Really Want Health Care’
Reported Earlier, SPAC Berto To Combine With AMPERA At About $900M Pre-Money Equity Value; Up To $357M Gross Cash Proceeds Expected